Tuesday, March 17, 2026

South Korea Redevelops Its North Korean Approach

The Ministry of National Defense has renamed...

U.S. Eyes Stronger Ties with Korea and Japan Amid NATO Talks

The U.S. Department of State evaluated South...

Skin Cancer Surges in South Korea: A 700% Rise Over 20 Years

Skin cancer, once relatively rare among South Koreans, has surged sevenfold over the past two decades. Here's what you need to know!

Tag: SK Bioscience

Why Ebola Now? SK Bioscience Joins a $30 Million Global Push to Rethink Ebola Vaccine Production

SK Bioscience secures funding to enhance Ebola vaccine production, improving yield and stability for better accessibility amid outbreaks.

How SK Bioscience Plans to Dominate the Global Vaccine Market in 2026

SK Bioscience enhances its operational system with new COO and key appointments to boost global competitiveness and vaccine development.

Top News

- Our Sponsors Ad -

Follow us